Description: Investigate the concept of value annuities and the potential cost-effective differences when compared to traditional annuities by attending this webcast. Value annuities are an alternative lifetime income solution where longevity and investment risks are born by a pool of annuitants rather than a centralized insurer. Join this webcast for a closer look at the practicalities of designing and administering a value pool. There will also be a focus on the legislative, regulator and supervisory implications.

Description: It comes as no surprise that there has been a great deal of activity by regulators in trying to understand the evolution of UW and the use of data. CO, WA, DC, CA, and on and on. But, where are we now? What is the latest activity? What are the technical issues that need to be considered? What testing protocols should carriers be preparing? How do you know what to look for with respect to fairness concerns? How do you prepare your company to test and if necessary defend your data practices? Join this panel discussion, where they will bring varying perspectives from some of the industry's leading voices on this topic.

Description: The American Academy of Actuaries Health Solvency Subcommittee and the NAIC Health Risk-Based Capital (E) Working Group are in the process of analyzing and reviewing the H2-Underwriting Risk component and the managed care credit calculation in the health risk-based capital (HRBC) formula. Come learn what changes are ahead! While RBC is designed for solvency issues, also come hear about other ways health insurers manage their capital and surplus levels. Are others doing something you should try?

Description: Come hear from a panel focused on hot topics in the life/LTC combination product market. The presenters will look at regulatory developments, evolution of the risk selection process, and provide an update to the assumption of natural risk hedging in hybrid products.

Description: The world of climate risk disclosures has seen dizzying levels of change in the last few years. In 2023, many regulators have publicly issued guidance on what insurance companies and other FIs should look to disclose. So what are we seeing in these disclosures and how do we use this information? Join our panel of experts to learn about the evolution of U.S. life insurance industry's climate disclosures and how insurers of all sizes and complexities are responding to NAIC's requirements.

Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.

Description: A changing workforce on a global scale, along with the cost and administrative burden of running retirement plans, has led to an increasing number of workers without access to company sponsored retirement plans. In addition, even when coverage exists, many national retirement and social security systems lack payout systems that provide true retirement security. Explore different retirement systems and uncover an overview of available and developing solutions to address these gaps in coverage and retirement security.

Description: Join us for an insightful webcast as we delve into the far-reaching implications of the recent Supreme Court decision to overturn Chevron deference. This landmark ruling, which previously granted federal agencies significant leeway in interpreting ambiguous statutes, is set to reshape the landscape of healthcare policy.

Description: How are regulation and innovation intertwined? How to regulate artificial intelligence/machine learning in the insurance industry? We will cover how regulators are striking the balance between protection of their constituents and supporting innovation. We will zoom into the case of predictive analytics and the regulatory attempt at avoiding undue discrimination. Let's discuss what this really mean.

Description: This session will provide insights into current industry allocations to asset classes with a focus on emerging and growing allocations to complex assets. Additionally, participants will gain an understanding of the risks associated with complex assets and the associated regulatory discussions.